Fosun Pharma Invites Chinese and Foreign Experts to Jointly Discuss Prevention and Control Measures of COVID-19 Epidemic in Africa
(29 April 2020, Shanghai) In order to support African medical institutions in their response to the COVID-19 pandemic, Fosun Pharma, partnering with Shanghai Fosun Foundation, Fosu...
World Malaria Day 2020 | Eliminating Malaria & Preventing COVID-19, Zero Malaria Starts with Me
(April 25 2020, Shanghai) On World Malaria Day 2020, countries across the world are trying to contain the spread of COVID-19 pandemic. At the same time, African countries are facin...
Fosun Pharma Announces 2019 Annual Results
（31 March, 2020, Shanghai）March 30 2020, Shanghai Fosun Pharmaceutical (Group) Co., Ltd ("Fosun Pharma"; Stock Code: 600196.SH, 02196.HK), a leading healthcare group in China, anno...
Fosun Kite’s Axicabtagene Ciloleucel Granted Priority Review by China NMPA
Summary: Fosun Kite’s autologous CD19-directed CAR-T cell therapy Axicabtagene Ciloleucel has been granted priority review status by China NMPA
Fosun Pharma and BioNTech form COVID-19 vaccine strategic alliance in China
Fosun Pharma has been licensed by BioNTech to exclusively develop and commercialize COVID-19 vaccines based on its mRNA technology platform in China
Fosun Pharma will commercializ...
Fosun Pharma Receives NMPA Approval to Initiate Phase III Clinical Trial for its Tenapanor Tables
（12 March, 2020, Shanghai）Recently, Shanghai Fosun Pharmaceutical (Group) Co., Ltd (“Fosun Pharma”; stock code: 600196.SH, 02196.HK) announced that its subsidiary Fosun Pharma Indu...